RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies

Clinical trial NCT04844086 · TERMINATED

Trial details

NCT number: NCT04844086
Sponsor: Eden BioCell Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma, Relapsed Non-Hodgkin's Lymphoma Refractory Primary Mediastinal Large B Cell Lymphoma Diffuse Large B Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma High-grade B-cell Lymphoma

Start date: 2021-03-02
Primary completion: 2022-05-12
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.